ADT1076-Befovacimab Biosimilar-(TFPI)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1076 |
Product Name |
ADT1076-Befovacimab Biosimilar-(TFPI)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-TFPI antibody, anti TFPI antibody, recombinant TFPI, TFPI antibody, anti-TFPI monoclonal antibody, TFPI antibodies, TFPI recombinant antibody, TFPI blocking antibody |
|
Alias |
Anti-TFPI, NN7415, mab2021 |
Host |
CHO Cells |
Species |
Human |
Target |
TFPI |
Gene ID |
7035 |
Isotype |
IgG4 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1312299-39-0 |
Product Description |
Concizumab has been used in trials studying the treatment of Haemophilia A and Congenital Bleeding Disorder. |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Wood JP, et al. Proc Natl Acad Sci U S A, 2013 Oct 29. PMID 24127605, Free PMC Article
2. The intron 7 -33T>C polymorphism in TFPI gene and cerebral venous thrombosis: evidence for a protective role. Prabhakar P, et al. Thromb Res, 2012 Oct. PMID 22836130
3. Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis. Winckers K, et al. J Thromb Haemost, 2012 Oct. PMID 22900482
|